Your browser doesn't support javascript.
loading
Different associations between body mass index and Alzheimer's markers depending on metabolic health.
Lee, Eun Hye; Yoo, Heejin; Kim, Young Ju; Cheon, Bo Kyoung; Ryu, Seungho; Chang, Yoosoo; Yun, Jihwan; Jang, Hyemin; Kim, Jun Pyo; Kim, Hee Jin; Koh, Seong-Beom; Jeong, Jee Hyang; Na, Duk L; Seo, Sang Won; Kang, Sung Hoon.
Afiliación
  • Lee EH; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
  • Yoo H; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
  • Kim YJ; Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea.
  • Cheon BK; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
  • Ryu S; Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea.
  • Chang Y; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
  • Yun J; Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea.
  • Jang H; Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim JP; Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim HJ; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
  • Koh SB; Department of Neurology, Soonchunhyang University Bucheon Hospital, Gyeonggi-do, Republic of Korea.
  • Jeong JH; Department of Neurology, Seoul National University Hospital, Seoul National University college of Medicine, Seoul, Republic of Korea.
  • Na DL; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
  • Seo SW; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
  • Kang SH; Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea.
Alzheimers Res Ther ; 16(1): 194, 2024 Aug 29.
Article en En | MEDLINE | ID: mdl-39210402
ABSTRACT

BACKGROUND:

Increasing evidence supports the association between body mass index (BMI), Alzheimer's disease, and vascular markers. Recently, metabolically unhealthy conditions have been reported to affect the expression of these markers. We aimed to investigate the effects of BMI status on Alzheimer's and vascular markers in relation to metabolic health status.

METHODS:

We recruited 1,736 Asians without dementia (71.6 ± 8.0 years). Participants were categorized into underweight, normal weight, or obese groups based on their BMI. Each group was further divided into metabolically healthy (MH) and unhealthy (MU) groups based on the International Diabetes Foundation definition of metabolic syndrome. The main outcome was Aß positivity, defined as a Centiloid value of 20.0 or above and the presence of vascular markers, defined as severe white matter hyperintensities (WMH). Logistic regression analyses were performed for Aß positivity and severe WMH with BMI status or interaction terms between BMI and metabolic health status as predictors. Mediation analyses were performed with hippocampal volume (HV) and baseline Mini-Mental State Examination (MMSE) scores as the outcomes, and linear mixed models were performed for longitudinal change in MMSE scores.

RESULTS:

Being underweight increased the risk of Aß positivity (odds ratio [OR] = 2.37, 95% confidence interval [CI] 1.13-4.98), whereas obesity decreased Aß positivity risk (OR = 0.63, 95% CI 0.50-0.80). Especially, obesity decreased the risk of Aß positivity (OR = 0.38, 95% CI 0.26-0.56) in the MH group, but not in the MU group. Obesity increased the risk of severe WMH (OR = 1.69, 1.16-2.47). Decreased Aß positivity mediate the relationship between obesity and higher HV and MMSE scores, particularly in the MH group. Obesity demonstrated a slower decline in MMSE (ß = 1.423, p = 0.037) compared to being normal weight, especially in the MH group.

CONCLUSIONS:

Our findings provide new evidence that metabolic health has a significant effect on the relationship between obesity and Alzheimer's markers, which, in turn, lead to better clinical outcomes.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Índice de Masa Corporal / Enfermedad de Alzheimer / Obesidad Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Alzheimers Res Ther Año: 2024 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Índice de Masa Corporal / Enfermedad de Alzheimer / Obesidad Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Alzheimers Res Ther Año: 2024 Tipo del documento: Article Pais de publicación: Reino Unido